DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ rose 3.10% to $823.82 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.71% to 7,631.47 and Dow Jones Industrial Average falling 0.79% to 52,766.88.
This was the stock's second consecutive day of gains.
Regeneron Pharmaceuticals Inc. closed 2.74% below its 52-week high of $847.00, which the company achieved on August 21st.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Amgen Inc. $(AMGN)$ rose 1.92% to $438.12, Moderna Inc. (MRNA) rose 9.93% to $154.27, and Gilead Sciences Inc. (GILD) rose 2.45% to $149.92.
Trading volume (672,060) remained 131,682 below its 50-day average volume of 803,742.
Data source: Dow Jones Market Data, FactSet. Data compiled September 1, 2026.